Lower riskDrug recall · FDA · Published May 23, 2025
Teva Metoclopramide Tablets 10mg Recall: Foreign Tablets Found
Teva recalls 100-count Metoclopramide 10mg tablets due to foreign tablets/capsules. Rx-only medication manufactured in Croatia. Check NDC 0093-2203-01 and lot 5420094.
“Teva Metoclopramide Tablets 10mg Recall: Foreign Tablets Found.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/32053-teva-metoclopramide-tablets-10mg-recall-foreign-tablets-found. Based on FDA recall #D-0473-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0473-2025%22&limit=1).
The FDA announced on May 23, 2025, that Teva Pharmaceuticals USA, Inc. is recalling Metoclopramide Tablets, USP 10 mg due to the presence of foreign tablets or capsules. Owners should contact the company for a refund.
How to tell if you have it
Brand: Teva Pharmaceuticals
Product: Metoclopramide Tablets, USP 10 mg
Packaging: 100-count bottle
NDC: 0093-2203-01
Lot code: 5420094
Expiration date: 09/30/2027
Quantity: 36,612 cartons
The hazard
The recall is due to the presence of foreign tablets or capsules in the product. The FDA classification is Class II.
Context
GovInfoNow's records show Teva Pharmaceuticals USA, Inc. has 59 other recalls on record since April 2, 2012. Other recent recalls of similar products include a Trazodone recall by Granules Pharmaceuticals on Jan. 26, 2026, and a Pitavastatin recall by Annora Pharma on Feb. 3, 2026.
How to tell if you have this one
Check for the NDC code 0093-2203-01 and lot number 5420094 on the bottle. The product was manufactured in Croatia by Pliva Hrvatska and distributed by Teva Pharmaceuticals.
Brand
Teva Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for NDC 0093-2203-01 and lot 5420094 on the bottle label.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 40 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0473-2025 (May 23, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0473-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.